Nearly all patients can be successfully treated without hospital admission, and avoid the devastating organ damage and blood clotting that can occur if the disease is allowed to progress, the authors state.
Instead of the "therapeutic nihilism" advocated by government agencies, these physicians, led by Baylor cardiologist Peter A. McCullough, M.D., propose urgent early intervention with sequenced, multidrug therapy.
This utilizes the early window of opportunity to prevent viral replication, rather than squandering time with a "wait and see" approach.
Many countries around the world encourage early treatment, in contrast to countries such as the US, Canada, Australia, the UK, Western Europe, and some South American countries, where lifesaving information may be censored, and governments refuse to support randomized clinical trials evaluating widely available, generic, inexpensive therapeutics, the article notes.
Physicians for Civil Defense provides information to help save lives in the event of natural or man-made disasters.
Peak Pharma Commercial Partners establishes Resilia Pharmaceuticals and starts operations
Nephron Pharmaceuticals Corporation receives USFDA approval over Ketorolac Tromethamine Injection
Amring gains global rights to LYSTEDA
Troy Medicare Closes USD 10m Series B Led by AXA Venture Partners
Breckenridge wins final FDA approval for Pomalidomide Capsules ANDA
Amneal Receives Abbreviated New Drug Application Approval for Acyclovir Cream, 5%
Cipla reports sharp rise in demand for COVID-19 drug remdesivir in India
Sandoz ships pantoprazole sodium to Civica Rx
Russia's Pharmasyntez seeks permission to produce COVID-19 drug without patent